STATE-OF-THE-ART PAPER
Management of Asymptomatic Severe Aortic Stenosis
Jacob P. Dal-Bianco, MD*,
Bjoy K. Khandheria, MBBS, FACC, FASE, FESC ,
Farouk Mookadam, MD, FRCP, MSc ,
Federico Gentile, MD and
Partho P. Sengupta, MBBS, MD, DM ,*
* Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, Arizona
Manuscript received May 5, 2008;
revised manuscript received June 30, 2008,
accepted July 1, 2008.
* Reprint requests and correspondence: Dr. Partho P. Sengupta, Division of Cardiovascular Diseases, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, Arizona 85259 (Email: sengupta.partho{at}mayo.edu).
Patients with symptomatic severe aortic stenosis (AS) benefit from aortic valve replacement (AVR). Management of severe AS in the absence of symptoms is, however, controversial and often challenging. Unselected premature AVR carries the risks of cardiac surgery; delayed AVR due to unrecognized symptoms can result in a dismal outcome. Echocardiography is the standard tool to evaluate and follow patients with AS. Nevertheless, most of the current echocardiographic parameters have limitations in predicting symptom onset and clinical outcome. The same applies to clinical parameters, exercise stress testing, and other imaging modalities used in AS evaluation and serial follow-up. Predictors of outcome could, however, help to identify asymptomatic patients who would benefit from expedited AVR with the goal to reduce mortality. This review will discuss the most relevant clinical studies and guidelines on management of asymptomatic severe AS, with an emphasis on providing concise information for identifying patients at high risk.
Key Words: aortic stenosis asymptomatic management outcome predictor severe
|
Abbreviations and Acronyms
| | ACC/AHA = American College of Cardiology/American Heart Association | | AS = aortic stenosis | | AVA = aortic valve area | | AVR = aortic valve replacement | | BAV = bicuspid aortic valve | | BNP = brain natriuretic peptide | | CI = confidence interval | | CR = contractile reserve | | ESC = European Society of Cardiology | | HR = hazard ratio | | LV = left ventricle/ventricular | | LVEF = left ventricular ejection fraction | | OR = odds ratio | | RR = relative risk |
|
Related Article
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A31.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
R. Rosenhek, R. Feneck, and F. Guarracino
Chapter 14a Aortic valve disease
The EAE Textbook of Echocardiography,
March 1, 2011;
1(1):
med-9780199599639-chapter - med-9780199599639-chapter.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Ngaage, J. Dickson, and L. Guvendik
Does Aortic Valve Replacement Mitigate the Risk of Preoperative Heart Failure?
Asian Cardiovasc Thorac Ann,
December 1, 2010;
18(6):
541 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Goel, P. P. Sengupta, F. Mookadam, H. P. Chaliki, B. K. Khandheria, and A. J. Tajik
Valvular regurgitation and stenosis: when is surgery required?
Heart Asia,
July 5, 2010;
1(1):
20 - 25.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Steadman, S. Ray, L. L. Ng, and G. P. McCann
Natriuretic Peptides in Common Valvular Heart Disease
J. Am. Coll. Cardiol.,
May 11, 2010;
55(19):
2034 - 2048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Kang, S. J. Park, J. H. Rim, S. C. Yun, D. H. Kim, J. M. Song, S. J. Choo, S. W. Park, J. K. Song, J. W. Lee, et al.
Early Surgery Versus Conventional Treatment in Asymptomatic Very Severe Aortic Stenosis
Circulation,
April 6, 2010;
121(13):
1502 - 1509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. G. Bakaeen, D. Chu, M. Ratcliffe, R. R. Gopaldas, A. S. Blaustein, R. Venkat, J. Huh, S. A. LeMaire, J. S. Coselli, and B. A. Carabello
Severe Aortic Stenosis in a Veteran Population: Treatment Considerations and Survival
Ann. Thorac. Surg.,
February 1, 2010;
89(2):
453 - 458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. E. Coglianese and R. Davidoff
Predicting Outcome in Patients With Asymptomatic Aortic Stenosis
Circulation,
July 7, 2009;
120(1):
9 - 11.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Hannan, Z. Samadashvili, S. J. Lahey, C. R. Smith, A. T. Culliford, R. S.D. Higgins, J. P. Gold, and R. H. Jones
Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality
Ann. Thorac. Surg.,
June 1, 2009;
87(6):
1741 - 1749.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|